semaglutide and neuropathy Translating Basic Science to Clinical Applications: A Narrative Review of Repurposed Pharmacological Agents in Preclinical Models of Diabetic A recent Veterans Health Administration–based

Tirzepatide's equivalent cardiovascular outcomes trial (SURPASS-CVOT) is still ongoing as of early 2026

The $299 a month price tag is affordable for Dunham for now, but she hopes the insurance industry might change or something more affordable might come along in the long term, she said

Age Considerations Not typically approved for type 1 diabetes

In adult clinical trials, severe GI adverse reactions were reported more frequently among patients receiving Wegovy than placebo

Consultation with a licensed medical provider is essential to determine the most appropriate treatment based on individual health needs and circumstances